-
- 抗原 See all NUP210 抗体
- NUP210 (Nucleoporin 210kDa (NUP210))
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This NUP210 antibody is conjugated to FITC
-
应用范围
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 特异性
- Human NUP210 / gp210
- 纯化方法
- Caprylic acid and ammonium sulfate precipitation
- 免疫原
-
Recombinant human Nuclear pore membrane glycoprotein 210 protein.
Type of Immunogen: Recombinant protein - 亚型
- IgG
- Top Product
- Discover our top product NUP210 Primary Antibody
-
anti-Nucleoporin 210kDa (NUP210) antibody
NUP210 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Nucleoporin 210kDa (NUP210) (AA 202-231), (N-Term) antibodyNUP210 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB23675 unconjugated
anti-Nucleoporin 210kDa (NUP210) (AA 209-239), (N-Term) antibodyNUP210 适用: 人 WB, FACS, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
-
Approved: ELISA, IHC, IHC-P, WB
Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. - 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- PBS, pH 7.4, 0.03 % Proclin 300, 50 % glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- Avoid freeze-thaw cycles.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
- 抗原
- NUP210 (Nucleoporin 210kDa (NUP210))
- 别名
- NUP210 / Gp210 (NUP210 产品)
- 别名
- 9830001L10 antibody, AI836801 antibody, Pom210 antibody, gp190 antibody, gp210 antibody, GP210 antibody, POM210 antibody, nucleoporin 210 antibody, nucleoporin 210kDa L homeolog antibody, NUP210 antibody, Nup210 antibody, nup210.L antibody
- 背景
-
Name/Gene ID: NUP210
Synonyms: NUP210, gp210, KIAA0906, Nucleoporin 210 kDa, Nucleoporin Nup210, Nuclear pore protein gp210, POM210 - 基因ID
- 23225
- 途径
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-
You are here:
